Skip to main content
The BMJ logoLink to The BMJ
letter
. 1994 Jan 15;308(6922):200. doi: 10.1136/bmj.308.6922.200b

Neuroleptic malignant syndrome. May be caused by other drugs.

P M Haddad
PMCID: PMC2542541  PMID: 8312781

Full text

PDF

Page 200

200

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bristow M. F., Kohen D. How "malignant" is the neuroleptic malignant syndrome? BMJ. 1993 Nov 13;307(6914):1223–1224. doi: 10.1136/bmj.307.6914.1223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Burke R. E., Fahn S., Mayeux R., Weinberg H., Louis K., Willner J. H. Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease. Neurology. 1981 Aug;31(8):1022–1025. doi: 10.1212/wnl.31.8.1022. [DOI] [PubMed] [Google Scholar]
  3. Kellam A. M. The (frequently) neuroleptic (potentially) malignant syndrome. Br J Psychiatry. 1990 Aug;157:169–173. doi: 10.1192/bjp.157.2.169. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES